Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Alex Dasalla - Head, IR Joseph Ciaffoni - President, CEO & Director Colleen Tupper - EVP & CFO Scott Dreyer - EVP & Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler & Co. David Steinberg - Jefferies John Boyle - William Blair & Company Rohit Bhasin - Needham & Company Gregory Fraser - Truist Securities Oren Livnat - H.C. Wainwright & Co. Operator Gr ...

August 5, 2021 Collegium Pharmaceutical, Inc. Q2 2021 Earnings Report Forward‐Looking Statements and use of Non‐GAAP Financial Measures | --- ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - President & Chief Executive Officer Paul Brannelly - Executive Vice President & Chief Financial Officer Scott Dreyer - Executive Vice President & Chief Commercial Officer Conference Call Participants Tim Lugo - William Blair David Steinberg - Jefferies David Amsellem - Piper Sandler Gregg Gilbert - Truist Securities Serge Belanger ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Jaffray Lachlan Hanbury-Brown - William Blair Serge Belanger - Needham & Company Brandon Folkes - Cantor Fitzgerald Kevin Kedra - G. Research Operator Greetings, and welc ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2020 Earnings Conference Call November 6, 2020 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler Lachlan Hanbury-Brown - William Blair Greg Fraser - Truist Securities Serge Belanger - Needham & Company David Steinberg - Jefferies Brandon Folkes - Cantor Fitzge ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Alex Dasalla - Head, IR Joseph Ciaffoni - President, CEO & Director Paul Brannelly - EVP & CFO Scott Dreyer - EVP & Chief Commercial Officer Conference Call Participants David Steinberg - Jefferies Gregory Gilbert - Truist Securities Serge Belanger - Needham & Company Brandon Folkes - Cantor Fitzgerald & Co. Dana Flanders - Guggenheim Securities David Amsellem - Piper Sandler & Co. Op ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2020 Earnings Conference Call May 7, 2020 4:30 AM ET Company Participants Alex Dasalla - Head, IR Joe Ciaffoni - President & CEO Paul Brannelly - CFO Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler Kevin Kedra - Gabelli and Company Serge Belanger - Needham & Company David Steinberg - Jefferies Operator Thank you and welcome to the Collegium Pharmaceutical, Inc Earnings Conference Call. I would now like to han ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2019 Results Conference Call February 27, 2020 5:00 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - President and Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Conference Call Participants Zach Sachar - Piper Sandler David Steinberg - Jefferies Serge Belanger - Needham & Company Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald Operator Good day, ladies and ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joseph Ciaffoni - President and Chief Executive Officer Paul Brannelly - Chief Financial Officer Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Jaffray David Steinberg - Jefferies & Company, Inc. Lachlan Hanbury-Brown - William Blair & Company Gregg Gilbert - SunTrust Robinson Humphrey Inc. Tian S ...

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2019 Results Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Alex Dasalla - Head, IR Joe Ciaffoni - CEO Paul Brannelly - CFO Scott Dreyer - Chief Commercial Officer Conference Call Participants David Amsellem - Piper Jaffray Greg Fraser - SunTrust Tian Sun - Needham & Company David Steinberg - Jefferies Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald Kevin Kedra - G. Research Operator Good day, and welcome to the Q2 2019 Col ...